Abstract: A composition of food or therapeutic and other substances for administration as a cloud of droplets, the cloud comprising readily-soluble droplets having a median size range of approximately 3 microns to approximately 20 microns, or 5 microns to 10 microns, or 6 microns to 10 microns, for introduction to an animal via an ortho-nasal or retro-nasal route. Agonists or antagonists may include one or more of the following: sodium iodide, sodium chloride, magnesium chloride, capsaicin, piperine, linalool, ground cinnamon, a cannabinoid, pimento, onion, clove, thyme, ginger, menthol, or TRPV antagonists, and chocolate, Irish cream, caramel, lemon, lime, mango, raspberry, watermelon, blueberry, strawberry, mint, popcorn, meat, Resolvin D2 or nicotine. Devices for delivering compositions as an aerosol are described.

Abstract: Hydration of a larynx and/or vicinity with a composition comprising a salt formulation (e.g., CaCl2), MgCl2, KCl and/or NaCl) can achieve prophylactic and/or therapeutic effects (e.g., cough suppression, improving voice quality, increasing pulse oxygen saturation and/or increasing mucosal vaccination effectiveness). The composition is administered as dry particles (e.g., aerosol) or as a liquid (e.g., solution, aerosol). The liquid can have a pH of 7.0 up to around 10.0, or preferably around 7.5 up to around 9.5, or more preferably around 8.0 up to around 9.0, or even more preferably 8.0 to 8.5 or most preferably around 8.0. The droplets can have a mass median aerodynamic diameter from approximately 8 ?m to approximately 15 ?m or from approximately 15 ?m to approximately 500 ?m. A therapeutic dose (e.g., 0.5 mg to 4.0 mg mass of salt) is administered in response to an indication. Such can employ an osmolitically active composition.

Abstract: Salt-based non-therapeutic hygienic formulations or compositions or therapeutic formulations or compositions, for example those rich in calcium, are effective against airborne pathogens, suppressing virus shedding, for instance by increasing a surface viscoelasticity of airway lining fluid. Associated apparatus, methods and articles are used to deliver salt-based non-therapeutic hygienic formulations or compositions as hygienic treatments to the upper respiratory tract. Associated apparatus, methods and articles are used to deliver salt-based therapeutic antimicrobial formulations or compositions to the upper respiratory tract. For example, nasal delivery of calcium-rich salines with aerosol droplet size of around 10 ?m (e.g., 7 ?m-15 ?m, or more preferably 9 ?m-10 ?m) may advantageously limit distribution to the nose and upper airways of the respiratory tract, suppressing bioaerosol generation.

Abstract: A composition of food or therapeutic and other substances for administration as a cloud of droplets, the cloud comprising readily-soluble droplets having a median size range of approximately 3 microns to approximately 20 microns, or 5 microns to 10 microns, or 6 microns to 10 microns, for introduction to an animal via an ortho-nasal or retro-nasal route. Agonists or antagonists may include one or more of the following: sodium iodide, sodium chloride, magnesium chloride, capsaicin, piperine, linalool, ground cinnamon, a cannabinoid, pimento, onion, clove, thyme, ginger, menthol, or TRPV antagonists, and chocolate, Irish cream, caramel, lemon, lime, mango, raspberry, watermelon, blueberry, strawberry, mint, popcorn, meat, Resolvin D2 or nicotine. Devices for delivering compositions as an aerosol are described.

Abstract: A scent release system includes scent cartridges containing temperature activated scent media. The scent cartridges may bear machine-readable identification that specifies which scent media are carried by the cartridge. The scent release system can be controlled by a timer to initiate a phase change of the scent media to selectively release one or more scents, followed by a reverse phase change to selectively stop release of the respective scents. A scent release system in conjunction with a mobile electronic device, such as a smart phone, allows sending and receiving scent messages. The scent release system can be built into a case for the mobile electronic device, eliminating the need for a separate unit. A private scent delivery device in the form of a headset can be worn by users of a scent release system or by scent message recipients.

Abstract: Hydration of a larynx and/or vicinity with a composition comprising a salt formulation (e.g., CaCl2, MgCl2, KCl and/or NaCl) can achieve prophylactic and/or therapeutic effects (e.g., cough suppression, improving voice quality, increasing pulse oxygen saturation and/or increasing mucosal vaccination effectiveness). The composition is administered as dry particles (e.g., aerosol) or as a liquid (e.g., solution, aerosol). The liquid can have a pH of 7.0 up to around 10.0, or preferably around 7.5 up to around 9.5, or more preferably around 8.0 up to around 9.0, or even more preferably 8.0 to 8.5 or most preferably around 8.0. The droplets can have a mass median aerodynamic diameter from approximately 8 µm to approximately 15 µm or from approximately 15 µm to approximately 500 µm. A therapeutic dose (e.g., 0.5 mg to 4.0 mg mass of salt) is administered in response to an indication. Such can employ an osmolitically active composition.

Abstract: Salt-based non-therapeutic hygienic formulations or compositions or therapeutic formulations or compositions, for example those rich in calcium, are effective against airborne pathogens, suppressing virus shedding, for instance by increasing a surface viscoelasticity of airway lining fluid. Associated apparatus, methods and articles are used to deliver salt-based non-therapeutic hygienic formulations or compositions as hygienic treatments to the upper respiratory tract. Associated apparatus, methods and articles are used to deliver salt-based therapeutic antimicrobial formulations or compositions to the upper respiratory tract. For example, nasal delivery of calcium-rich salines with aerosol droplet size of around 10 ?m (e.g., 7 ?m-15 ?m, or more preferably 9 ?m-10 ?m) may advantageously limit distribution to the nose and upper airways of the respiratory tract, suppressing bioaerosol generation.

Abstract: A system to provide media (e.g., scent, therapeutics, other substances) includes a dispenser that may include a reservoir, an actuator (e.g., nebulizer), and an outlet through which a vapor or aerosol may be supplied or dispensed, the vapor or aerosol, for example comprising readily-soluble droplets having a median size range of approximately 2 microns to approximately 50, 20, or 10 microns for introduction to vessel. An interface is positionable over an opening of the vessel to close the opening while allow media to be dispensed into the interior of the vessel, thereby retaining the dispensed media until taken in by a user. The interface (e.g., annular plate) has a pair of opposed major surfaces, and the first major face supported on a rim of the vessel, with the dispenser supported on the second major face in an inverted orientation. A sensor may sense orientation, and cause an actuator (e.g., nebulizer) to dispense media when in the inverted orientation or otherwise titled for normal.

Abstract: An apparatus to provide scent or other substances (e.g., active agent) includes a thin profile delivery apparatus that includes an actuator (e.g., nebulizer) and drive circuit to generate a spray, aerosol or vapor. The apparatus may have a slot to removably a media cartridge that carries the scent or other substances. The apparatus may include two contacts (e.g., buttons), opposed to one another across a dimension of the apparatus. Activation may require both engagement of both contacts, for instance concurrently, or even successive engagement of both contacts, in quick succession. Activation may further require a correct orientation of the apparatus. The apparatus may have a form factor similar to a conventional credit or debit card, and may be pliable or pliably resilient. The delivery apparatus can be used in entertainment (e.g., food or cooking programming), and in healthcare (e.g., control of metabolism).

Abstract: An oil tank filling system for filling the oil tank of a gas turbine engine that includes an aft core cowl. The system includes an oil tank that has an oil tank top and an oil tank bottom and is located within a core of the engine, an oil access port located on the aft core cowl, and an oil tank filling pipe that leads from the oil access port to a tank filling port located at or adjacent the oil tank bottom. The system is configured so that oil that is supplied to the oil access port flows to and into the oil tank using gravitational force. A method of filling the oil tank of a gas turbine engine and a gas turbine engine that includes the oil tank filling system.

Abstract: Salt-based non-therapeutic hygienic formulations or compositions or therapeutic formulations or compositions, for example those rich in calcium, are effective against airborne pathogens, suppressing virus shedding, for instance by increasing a surface viscoealasticity of airway lining fluid. Associated apparatus, methods and articles are used to deliver salt-based non-therapeutic hygienic formulations or compositions as hygienic treatments to the upper respiratory tract. Associated apparatus, methods and articles are used to deliver salt-based therapeutic antimicrobial formulations or compositions to the upper respiratory tract. For example, nasal delivery of calcium-rich salines with aerosol droplet size of around 10 ?m (e.g., 7 ?m-15 ?m, or more preferably 9 ?m-10 ?m) may advantageously limit distribution to the nose and upper airways of the respiratory tract, suppressing bioaerosol generation.

Abstract: A gas turbine engine for an aircraft including a unit supplied with oil from a first oil circuit and a second oil circuit. The first oil circuit and the second oil circuit each are fluidly coupled with at least one inlet and with at least one outlet of the unit and with at least one inlet and with at least one outlet of an oil tank. The first oil circuit and the second oil circuit are configured to receive oil from the oil tank and to direct the received oil to the unit. The oil tank is incorporating offset outlets to each of the oil circuits. The offset outlet of the second oil circuit is positioned higher in the oil tank than the offset outlet of the first oil circuit.

Abstract: The disclosure relates to a gas turbine engine having an accessory gearbox assembly having an accessory gearbox. The accessory gearbox assembly is mounted adjacent a core of the gas turbine engine and has a support formation for supporting a conduit. The conduit extends between a first location on the engine and a second location on the engine. The first location and the second location may be spaced from the accessory gearbox such that the conduit does not operatively communicate with the accessory gearbox in use. The accessory gearbox may be axially mounted and may provide a bridge for supporting a plurality of conduits.

Abstract: An edible composition, particularly an edible transport system, comprising an edible substance and a cross-linked matrix encapsulating the edible substance, the cross-linked matrix comprising (1) at least one edible polymer and edible particles or (2) a plurality of edible polymers.

Abstract: An oil tank filling system for filling the oil tank of a gas turbine engine. The system includes an oil tank located within a core of the engine, an oil filling reservoir located within a bifurcation that extends from the core of the engine, an oil tank filling pipe that leads from the oil filling reservoir to a tank filling port on the oil tank, and an oil pump. The system is configured so that the oil pump pumps oil from the oil filling reservoir through the oil tank filling pipe and the tank filling port to fill the oil tank. A method of filling the oil tank of a gas turbine engine and a gas turbine engine that includes the oil tank filling system are also disclosed.

Abstract: A composition of food or therapeutic and other substances for administration as a cloud of droplets, the cloud comprising readily-soluble droplets having a median size range of approximately 3 microns to approximately 20 microns, or 5 microns to 10 microns, or 6 microns to 10 microns, for introduction to an animal via an ortho-nasal or retro-nasal route. Agonists or antagonists may include one or more of the following: sodium iodide, sodium chloride, magnesium chloride, capsaicin, piperine, linalool, ground cinnamon, a cannabinoid, pimento, onion, clove, thyme, ginger, menthol, or TRPV antagonists, and chocolate, Irish cream, caramel, lemon, lime, mango, raspberry, watermelon, blueberry, strawberry, mint, popcorn, meat, Resolvin D2 or nicotine. Devices for delivering compositions as an aerosol are described.

Abstract: A gas turbine engine includes a gearbox receiving input from a core shaft and driving a fan at a lower speed than the core shaft. First and second oil circuits fluidly couple with an inlet and outlet of the gearbox. A third oil circuit fluidly couples with an inlet and outlet of the gearbox. The outlet of the gearbox includes a device directing oil from the gearbox to the first oil circuit, to the second oil circuit and to the third oil circuit when feeding to the gearbox exceeds a predefined oil flow rate, or deviates an operational value corresponding with that oil flow rate, and directs oil from the gearbox to the third oil circuit when feeding to the gearbox is ? the predefined flow rate or is ? a corresponding operational value or is greater than or equal to a further corresponding operational value.

Abstract: An auxiliary oil supply apparatus for a rotating device (50, 51), the rotating device comprising a primary oil supply (52), a rotating component (50) and a static component (51) situated radially outwardly of a centre of rotation of the rotating component (50) and arranged to collect oil (58) held radially outwardly from the rotating component (50) as the rotating component rotates. The auxiliary oil apparatus comprises a scoop (56) associated with the rotating component (50) and is responsive to a change in a known parameter to move between a first position in the static component (51) to a second position between the static component (51) and the centre of rotation.

Abstract: A tank assembly (100) for a gas turbine engine is provided comprising a tank (102) and a plurality of restraints (112, 114). The restraints (112, 114) include a fixing part (124) for securing the tank (102) to a support structure (104). A first restraint (112) has a first rigidity in the direction of a length of the tank (102) and at least one second restraint (114) has a second rigidity in the direction of the length of the tank (102). Upon thermal expansion or contraction of the tank (102) relative to the support structure (104), the or each second restraint (114) flexes to a greater extent than the first restraint (112).

Abstract: An oil tank filling system for filling the oil tank of a gas turbine engine that includes an aft core cowl. The system includes: an oil tank that is located within a core of the engine; an oil access port located on the aft core cowl; an oil tank filling pipe that connects the oil access port to a tank filling port on the oil tank; and a hydraulic lock that prevents oil entering the oil tank once the oil tank contains a predetermined volume of oil. A method of filling the oil tank of a gas turbine engine and a gas turbine engine that includes the oil tank filling system are also disclosed.